PT81624B - Metodos recombinantes para a producao de inibidores da protease serina e metodos para o isolamento dos mesmos - Google Patents

Metodos recombinantes para a producao de inibidores da protease serina e metodos para o isolamento dos mesmos

Info

Publication number
PT81624B
PT81624B PT81624A PT8162485A PT81624B PT 81624 B PT81624 B PT 81624B PT 81624 A PT81624 A PT 81624A PT 8162485 A PT8162485 A PT 8162485A PT 81624 B PT81624 B PT 81624B
Authority
PT
Portugal
Prior art keywords
methods
production
serin
protease
inhibitors
Prior art date
Application number
PT81624A
Other languages
English (en)
Other versions
PT81624A (en
Inventor
Robert C Thompson
Pradip K Bandyopadhyay
Stephen P Eisenberg
Gary L Steller
Original Assignee
Synergen Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27102096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT81624(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synergen Biolog Inc filed Critical Synergen Biolog Inc
Publication of PT81624A publication Critical patent/PT81624A/pt
Publication of PT81624B publication Critical patent/PT81624B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PT81624A 1984-12-06 1985-12-05 Metodos recombinantes para a producao de inibidores da protease serina e metodos para o isolamento dos mesmos PT81624B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67882284A 1984-12-06 1984-12-06
US80347185A 1985-12-02 1985-12-02

Publications (2)

Publication Number Publication Date
PT81624A PT81624A (en) 1986-01-01
PT81624B true PT81624B (pt) 1987-10-20

Family

ID=27102096

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81624A PT81624B (pt) 1984-12-06 1985-12-05 Metodos recombinantes para a producao de inibidores da protease serina e metodos para o isolamento dos mesmos

Country Status (18)

Country Link
EP (1) EP0205475B2 (pt)
JP (1) JP2683500B2 (pt)
AT (1) ATE108205T1 (pt)
AU (1) AU590238B2 (pt)
CA (1) CA1296273C (pt)
DD (1) DD253642A5 (pt)
DE (1) DE3587875T3 (pt)
DK (1) DK372086D0 (pt)
FI (1) FI108943B (pt)
GR (1) GR852940B (pt)
HU (1) HU204563B (pt)
IE (1) IE64175B1 (pt)
IL (3) IL95223A (pt)
MX (1) MX9203519A (pt)
NO (1) NO301122B1 (pt)
NZ (1) NZ214456A (pt)
PT (1) PT81624B (pt)
WO (1) WO1986003519A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291662B1 (en) 1984-12-05 2001-09-18 Amgen Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences
US5871956A (en) * 1984-12-06 1999-02-16 Amgen Inc. Recombinant methods for production of serine inhibitors and DNA sequences useful for same
US6132990A (en) * 1984-12-06 2000-10-17 Amgen Boulder Inc. Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
US5900400A (en) * 1984-12-06 1999-05-04 Amgen Inc. Serine protease inhibitor analogs
ATE92935T1 (de) * 1984-12-06 1993-08-15 Synergen Biolog Inc Serinproteaseinhibitoren und isolierungsverfahren dazu.
AU589935B2 (en) * 1985-01-07 1989-10-26 Celltech Limited Recombinant DNA processes for the production of tissue inhibitor of metalloproteinase
DE3600571A1 (de) * 1986-01-10 1987-08-06 Gruenenthal Gmbh Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel
US5278049A (en) * 1986-06-03 1994-01-11 Incyte Pharmaceuticals, Inc. Recombinant molecule encoding human protease nexin
JPH0616716B2 (ja) * 1986-10-14 1994-03-09 塩野義製薬株式会社 酵母におけるヒトpstiの製造法
WO1988003171A1 (en) * 1986-10-30 1988-05-05 Synergen Biologicals, Inc. Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same
GB2199582A (en) * 1987-01-07 1988-07-13 Bayer Ag Analogues of pancreatic secretory trypsin inhibitor
US5851983A (en) * 1987-12-28 1998-12-22 Teijin Limited Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
EP0332576B1 (de) * 1988-03-07 1994-04-06 Ciba-Geigy Ag Modifizierte Proteine
US5180667A (en) * 1988-03-07 1993-01-19 Ciba-Geigy Corporation Genes encoding eglin C mutants
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5646015A (en) * 1988-08-31 1997-07-08 Astra Ab Excretion of heterologous proteins from E. coli
US6869925B1 (en) * 1992-09-09 2005-03-22 Amgen Inc. Inhibition of retrovirus infection
US6017880A (en) * 1994-03-09 2000-01-25 Amgen Inc. Inhibition of retrovirus infection
CN1144488A (zh) * 1994-03-23 1997-03-05 东京田边制药株式会社 新型呼吸道病毒性疾病治疗药物
US5633227A (en) * 1994-09-12 1997-05-27 Miles, Inc. Secretory leukocyte protease inhibitor as an inhibitor of tryptase
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US7247704B2 (en) 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
GR79124B (pt) * 1982-12-22 1984-10-02 Genentech Inc
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
DE122080T1 (de) * 1983-03-25 1985-05-23 Celltech Ltd., Slough, Berkshire Verfahren zur herstellung eines proteins.
JPS60186290A (ja) * 1983-08-10 1985-09-21 チモ−ジエネテイツクス インコ−ポレ−テツド アルフア−1−アンチトリプシンを細菌に表現させる方法
US4711848A (en) * 1984-03-14 1987-12-08 Zymogenetics, Inc. Site specific mutagenesis in alpha-1-antitrypsin

Also Published As

Publication number Publication date
EP0205475A1 (en) 1986-12-30
NO863182L (no) 1986-08-06
GR852940B (pt) 1986-04-07
JP2683500B2 (ja) 1997-11-26
IL95223A0 (en) 1991-06-10
NO301122B1 (no) 1997-09-15
AU5202986A (en) 1986-07-01
CA1296273C (en) 1992-02-25
AU590238B2 (en) 1989-11-02
DE3587875T2 (de) 1994-10-13
HUT41442A (en) 1987-04-28
IL77227A (en) 1992-08-18
IE853083L (en) 1986-06-06
PT81624A (en) 1986-01-01
FI863188A (fi) 1986-08-05
EP0205475B1 (en) 1994-07-06
ATE108205T1 (de) 1994-07-15
FI863188A0 (fi) 1986-08-05
NO863182D0 (no) 1986-08-06
FI108943B (fi) 2002-04-30
HU204563B (en) 1992-01-28
DK372086A (da) 1986-08-05
DE3587875D1 (de) 1994-08-11
DE3587875T3 (de) 2003-01-02
JPH06315384A (ja) 1994-11-15
EP0205475A4 (en) 1990-06-27
MX9203519A (es) 1992-08-01
DK372086D0 (da) 1986-08-05
DD253642A5 (de) 1988-01-27
NZ214456A (en) 1988-02-12
IL95223A (en) 1992-08-18
EP0205475B2 (en) 2002-09-04
WO1986003519A1 (en) 1986-06-19
IE64175B1 (en) 1995-07-12

Similar Documents

Publication Publication Date Title
PT81624B (pt) Metodos recombinantes para a producao de inibidores da protease serina e metodos para o isolamento dos mesmos
TR199801794T2 (xx) �nsan bikunini.
RU95115239A (ru) Аналог эритропоэтина
DE69433934D1 (de) Verfahren und Zusammensetzungen zur erhöhten Proteinproduktion von rekombinanter DNA
BR9711795A (pt) Peptìdeos tendo propriedades antiproliferativas
DE69831007D1 (de) Humane checkpointkinase, hcds1, zusammensetzungen und verfahren
DE3688324D1 (de) Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel.
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
FI892690A0 (fi) Menetelmä trombiinia inhiboivan vaikutuksen omaavan amblyommiinin eristämiseksi
DE3584029D1 (de) Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
ATE362768T1 (de) Prb2/p130 peptidinhibitoren der cdk2 kinaseaktivität
DE69319831T2 (de) Methode zur Sequenzanalyse C-terminaler Peptidfragmente
ES8700691A1 (es) Un metodo para sintetizar por adn recombinante un inhibidor de serin-proteasa con una unica cadena polipeptidica
IT1278118B1 (it) Polipeptide per la riparazione di informazione genetica, sequenza nucleotidica che codifica per esso e procedimento per la sua
TH62241A (th) ไบคูนินของคน
DE3888078D1 (de) Veränderungsverfahren für Peptide und Proteine.

Legal Events

Date Code Title Description
PC3A Transfer or assignment

Free format text: 19991206 AMGEN INC. US